Skip to main content
ConductScienceScienceDex

Christopher Barron

NIH Rank #9479
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 78959243Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$1.6M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#9,479
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christopher Barron. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award data coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2025): $1.6M in linked award amounts across 2 award records · Award-linked rank #9479.

FY2025 award records by amount

NIH award records listing Christopher Barron as a PI. Multi-PI records show the full award amount for context.

  • 1R44CA310518-01R44
    CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer
    Embiosys Inc.
    $1.4M
    award amount
  • 5R43CA287836-02R43
    DEVELOPMENT OF A WEARABLE, NON-INVASIVE, TREATMENT DEVICE FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC)
    Embiosys Inc.
    $188.9K
    award amount

Award organization

Organizations that administered FY2025 awards listing Christopher Barron as a PI.

FY2025 award administered by Embiosys Inc. (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Embiosys Inc.
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Entered Top 50% Nationally
    Ranked #9479

Explore further

Find collaborators for Christopher Barron

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →